KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

PHASE4CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

September 27, 2019

Conditions
Chronic Kidney DiseasesIron Deficiency Anemia
Interventions
DRUG

KRX-0502

Oral ferric citrate with meals

Trial Locations (28)

11021

Division of Kidney/HTN Research, Great Neck

27834

Eastern Nephrology Associates, Greenville

28207

Metrolina Nephrology Associates, PA, Charlotte

28401

Southeastern Nephrology, Wilmington

28546

Southeastern Nephrology Associates, Jacksonville

28562

Eastern Nephrology Associates, New Bern

28801

Mountain Kidney & Hypertension Associates, Asheville

29118

South Carolina Nephrology & Hypertension Center, Inc, Orangeburg

29203

Columbia Nephrology Associates, PA, Columbia

30904

Southeastern Clinical Research Institute, LLC, Augusta

31904

Renal Associates, LLC, Columbus

33143

Miami Kidney Group, Miami

33150

Kidney and Hypertension Specialists of Miami, P.A., Miami

37205

Nephrology Associates, P.C., Nashville

39501

South Mississippi Medical Research, LLC, Gulfport

60643

Research by Design, LLC, Chicago

64111

Clinical Research Consultants, Kansas City

75904

P & I Clinical Research, LLC, Lufkin

78212

Clinical Advancement Center, PLLC, San Antonio

78751

Research Management, Inc., Austin

78758

Research Management, Inc., Austin

80230

Denver Nephrologists, P.C., Denver

85032

Arizona Kidney Disease and Hypertension center: AKDHC Medical Research Services, LLC, Phoenix

89511

Sierra Nevada Nephrology Consultants, Reno

91910

California Institute of Renal Research, Chula Vista

92064

California Institute of Renal Research, Poway

92243

California Institute of Renal Research, El Centro

07724

Hypertension and Nephrology Association, Eatontown

Sponsors
All Listed Sponsors
lead

Keryx Biopharmaceuticals

INDUSTRY